Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - CA
$ 1.865
-2.63 %
$ 719 M
Market Cap
16.82
P/E
1. INTRINSIC VALUE
Balance Sheet
Cronos Group Inc.
| Current Assets | 936 M |
| Cash & Short-Term Investments | 859 M |
| Receivables | 29.8 M |
| Other Current Assets | 47.5 M |
| Non-Current Assets | 230 M |
| Long-Term Investments | 2.81 M |
| PP&E | 135 M |
| Other Non-Current Assets | 92.8 M |
| Current Liabilities | 49.7 M |
| Accounts Payable | 17 M |
| Short-Term Debt | 0 |
| Other Current Liabilities | 32.7 M |
| Non-Current Liabilities | 5.63 M |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 5.63 M |
EFFICIENCY
Earnings Waterfall
Cronos Group Inc.
| Revenue | 118 M |
| Cost Of Revenue | 92.4 M |
| Gross Profit | 25.2 M |
| Operating Expenses | 102 M |
| Operating Income | -76.5 M |
| Other Expenses | -117 M |
| Net Income | 40 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Cronos Group Inc.
| Net Income | 40 M |
| Depreciation & Amortization | 9.34 M |
| Capital Expenditures | -12.4 M |
| Stock-Based Compensation | 8.7 M |
| Change in Working Capital | -311 K |
| Others | -36.1 M |
| Free Cash Flow | 6.43 M |
Wall Street Analysts Price Targets
Cronos Group Inc.
Wall Street analysts predict an average 1-year price target for CRON of $3.15 , with forecasts ranging from
a
low of
$2.3 to a high of $4.5 .
CRON Lowest Price Target
Wall Street Target
2.3 USD
23.32%
CRON Average Price Target
Wall Street Target
3.15 USD
68.90%
CRON Highest Price Target
Wall Street Target
4.5 USD
141.29%
4. DIVIDEND
ANALYSIS
CRON does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Cronos Group Inc.
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
3 Marijuana Stocks For The Long Term Investing
Marijuana stocks hold lots of potential for home-run investments in the future. In 2018, most pot stocks saw their first wave of the green rush. Yet over the last several years, this has not been the case and things have changed drastically. Still, the way companies are keeping up with. Market demand profits and revenue are steadily rising. However, this success has played very little in how most marijuana stocks trade.
marijuanastocks.com
- 2 weeks ago
Cronos Group Inc. to Hold Virtual 2025 Annual Meeting of Shareholders
TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2025 Annual Meeting of Shareholders on Friday, June 20, 2025, at 11:00 a.m. ET.
globenewswire.com
- 3 weeks ago
3 Canadian Marijuana Stocks That Could See Big Future Gains
When it comes to finding marijuana stocks to buy a happy medium or silver lining at this time is tough to do. Not becuase the low share prices from some of the top-performing companies dont look appetizing. It is more due to the consistent falls in the sector no real upward push. Even as the cannabis industry as a whole is thriving and showing great long-term success.
marijuanastocks.com
- 1 month ago
2 Canadian Marijuana Stocks For Your Upcoming Watchlist
Marijuana stocks are torn between two ferns, and this has created a volatile frenzy in the sector. It could be that people feel the cannabis sector will eventually take the behavior of other sectors when in a less volatile space. Uncertainty brings lots of fears doubts, and caution on how to proceed in the future. Now with tariffs in place with China, packaging and other logistics concerns for businesses could lead to deeper issues and problems.
marijuanastocks.com
- 1 month ago
3 Canadian Marijuana Stocks For Long-Term Investing
Marijuana stock investors are torn between several paths. With how volatile the space is, much of the sector is trading at low price points. It is almost safe to say that more than half of those who have shares in a cannabis company are down. But that doesn't mean that it will stay that way forever. The overall cannabis industry continues to flourish even though that same success doesn't impact the public sector as it used to.
marijuanastocks.com
- 1 month ago
Top Canadian Cannabis Stocks to Watch in April 2025
Top Canadian cannabis stocks are attracting attention this week as investors seek opportunities in a rapidly evolving industry. Companies like Cronos Group, SNDL Inc., and Aurora Cannabis continue strengthening their positions in Canadian and international markets. Though based in Canada, these firms have exposure to the U.S. through strategic investments and partnerships. The U.S. cannabis industry is expected to generate over $45 billion annually by 2025. Legalization efforts are expanding, and several states are reviewing new adult-use and medical cannabis bills. At the same time, court rulings and state-level decisions continue to shape the legal landscape. Because of this, Canadian companies with U.S. exposure are drawing increased interest from traders and long-term investors alike.
marijuanastocks.com
- 1 month ago
Cronos Stock: Win Big Or Lose All
I maintain a 'strong buy' rating for Cronos, despite regulatory headwinds, due to its strong fundamentals and potential for multibagger returns. Cronos has shown positive progress with a robust cash buffer, 35% revenue growth, reduced EBITDA losses, and positive operating cash flows in FY 2024. International expansion, strategic investments, and a focus on R&D are key drivers for Cronos' sustained top-line growth and market diversification.
seekingalpha.com
- 1 month ago
3 Canadian Marijuana Stocks To Watch For Future Gains 2025
Marijuana stocks have been facing a downward trend in the market for some time. A big reason is regulatory uncertainty and reform issues. Legislative changes, particularly in major markets like the U.S., can greatly affect how shareholders think. Additionally, oversupply in certain regions has led to falling prices, which negatively affects revenue for companies in the sector. This has created a volatile sector where the trading behavior of the most public companies is more on the low end.
marijuanastocks.com
- 2 months ago
Cronos Appoints Anna Shlimak as Chief Financial Officer
TORONTO, March 19, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced the appointment of Anna Shlimak as Chief Financial Officer, effective today. Ms. Shlimak, who previously served as Cronos' Chief Strategy Officer, will succeed James Holm who is stepping down to pursue other opportunities and will remain with the Company through April 18, 2025 to ensure a seamless transition.
globenewswire.com
- 2 months ago
Cronos Group Inc. (CRON) 37th Annual Roth Conference (Transcript)
Cronos Group Inc. (NASDAQ:CRON ) 37th Annual Roth Conference March 17, 2025 4:00 PM ET Company Participants Mike Gorenstein - Chairman, President and Chief Executive Officer Conference Call Participants Bill Kirk - Roth Capital Partners Bill Kirk Awesome. Good afternoon everybody.
seekingalpha.com
- 2 months ago
Cronos Group Inc. to Speak at the 37th Annual Roth Conference
TORONTO, March 10, 2025 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Chairman, President and CEO, will speak at the 37th Annual Roth Conference on Monday, March 17, 2025, at 1:00 PM PT.
globenewswire.com
- 2 months ago
Cronos Reports Improved Q4-2024 Financials With Revenues From GrowCo
Cronos reported 27% increase in revenues YOY for Q4-2024. The company is now reporting revenues from its 50% ownership of GrowCo. The company reported increasing profits and free cash flow for the quarter.
seekingalpha.com
- 2 months ago
8. Profile
Summary
Cronos Group Inc. CRON
COUNTRY
CA
INDUSTRY
Drug Manufacturers - Specialty & Generic
MARKET CAP
$ 719 M
Dividend Yield
0.00%
Description
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Contact
111 Peter Street, Toronto, ON, M5V 2H1
https://www.thecronosgroup.com
IPO
Date
Feb. 27, 2018
Employees
459
Officers
Mr. James Andrew McGinness III
Vice President, Controller & Principal Accounting Officer
Mr. Jeffrey David Jacobson
Chief Growth Officer
Mr. James Holm
Executive Officer
Ms. Shannon Buggy
Senior Vice President & Global Head of People
Mr. Terry Gregory-Joseph Doucet
General Counsel & Corporate Secretary
Mr. Adam Wagner
Senior Vice President & Head of Cronos Israel